About Editas Medicine
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Investors & Backers
Editas Medicine has received investment from 1 venture capital firm.
Full portfolios: Third Rock Ventures portfolio
Frequently Asked Questions
What does Editas Medicine do?
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
Who invested in Editas Medicine?
Editas Medicine has received investment from Third Rock Ventures. These venture capital firms and investors provide both capital and strategic support.
What sector is Editas Medicine in?
Editas Medicine operates in the Biotech sector. Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Company Details
- Sector
- Biotech
- Headquarters
- located in Cambridge, Massachusetts
- Status
- Active
